Trade Arabia1h
Sudair Pharma to set up new insulin plant in Saudi Arabia
Saudi-based Sudair Pharma Company is set to establish its new insulin plant in the Sudair City for Industry and Businesses.
Insulin Pen And Pump Market Expansion Forecasted At 6.97% CAGR To 60.0 Billion USD By 2032 Abbott Laboratories, Roche
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
Tech advances ease lives of type 1 diabetic children and their parents
Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...
Most Type 1 diabetes patients feel lives are restricted due to their condition, survey finds
Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...
Over half of Type 1 diabetes patients feel their daily lives are restricted, survey shows
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
PharmiWeb1d
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
More than half of adults with ‘relentless’ condition say it stops them being spontaneous
MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...
Half of adults with Type 1 diabetes say condition limits spontaneity
A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...
TMCnet18h
Remote Patient Monitoring Market to Hit USD 56.94 Billion by 2030 with 12.7% CAGR | MarketsandMarkets™
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...
The New York Times29d
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
By Katie Thomas Maricruz Salgado was bringing her diabetes under control ... another patient at Erie Health who uses Lantus, an insulin pen. Last fall, after the 340B discount changed, she ...